Some related notes:

1. Yes, this is the transaction that Erin Griffith first sniffed out last week.

2. Word is that around half of the proceeds will be used for the Altos purchase, which is largely cash. No comment on this from the company, catch.

3. Flatiron will continue to be EMR agnostic, despite buying Altos. The comparison I heard was how the Flatiron founders previously created Invite Media, an exchange-agnostic ad-tech play that was bought by Google (GOOG) – but which continued to work with others. Same general theory, since Flatiron gains the most value by increasing its data
.
4. Expect Flatiron to try doubling its 30-person staff this year, while Altos also will have flexibility to grow (it currently has around 60 employees).

5. I really am fascinated by these sorts of companies – both ones working to centralize/analyze clinical data and also published research. What I do wonder, however, is if there will eventually be some sort of meta-big data engine that tries to sit on top of companies like Flatiron. Almost like Kayak and others did with travel. Obviously not apples-to-apples, but there are some similarities…

Sign up for Dan Primack’s daily email newsletter on deals and deal-makers: GetTermSheet.com